Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Liver Transplantation

  Free Subscription


Articles published in Transplantation

Retrieve available abstracts of 288 articles:
HTML format
Text format



Single Articles


    April 2018
  1. ARORA SS, Chahal KS, Axley P, Eckhoff DE, et al
    Heavy Alcohol Use Among Deceased Donors Does Not Impact Recipient Outcomes After Liver Transplantation.
    Transplantation. 2018 Apr 19. doi: 10.1097/TP.0000000000002230.
    PubMed     Text format     Abstract available


  2. HOGEN R, Lo M, DiNorcia J, Ji L, et al
    More Than Just Wait Time? Regional Differences in Liver Transplant Outcomes for Hepatocellular Carcinoma.
    Transplantation. 2018 Apr 18. doi: 10.1097/TP.0000000000002248.
    PubMed     Text format     Abstract available


  3. WU YJ, Wang SH, Elsarawy AM, Chan YC, et al
    Prediction of the Development of Persistent Massive Ascites after Living Donor Liver Transplantation Using a Perioperative Risk Score.
    Transplantation. 2018 Apr 5. doi: 10.1097/TP.0000000000002174.
    PubMed     Text format     Abstract available


  4. HONDA M, Sugawara Y, Kadohisa M, Shimata K, et al
    Long-term outcomes of ABO-incompatible pediatric living donor liver transplantation.
    Transplantation. 2018 Apr 3. doi: 10.1097/TP.0000000000002197.
    PubMed     Text format     Abstract available


  5. ALLEN AM, Heimbach JK, Larson JJ, Mara KC, et al
    Reduced access to liver transplantation in women: role of height, MELD exception scores and renal function underestimation.
    Transplantation. 2018 Apr 3. doi: 10.1097/TP.0000000000002196.
    PubMed     Text format     Abstract available


    March 2018
  6. TACKE F
    New insights on the role of Kupffer cells in liver transplantation.
    Transplantation. 2018 Mar 22. doi: 10.1097/TP.0000000000002193.
    PubMed     Text format    


  7. ZHAO Z, Pan G, Tang C, Li Z, et al
    IL-34 Inhibits Acute Rejection of Rat Liver Transplantation by Inducing Kupffer Cell M2 Polarization.
    Transplantation. 2018 Mar 22. doi: 10.1097/TP.0000000000002194.
    PubMed     Text format     Abstract available


  8. BRAUN HJ, Ascher NL
    The Impact of Renal Insufficiency Following Liver Transplantation.
    Transplantation. 2018 Mar 20. doi: 10.1097/TP.0000000000002176.
    PubMed     Text format    


  9. VANWAGNER LB, Montag S, Zhao L, Allen NB, et al
    Cardiovascular Disease Outcomes Related to Early Stage Renal Impairment Following Liver Transplantation.
    Transplantation. 2018 Mar 20. doi: 10.1097/TP.0000000000002175.
    PubMed     Text format     Abstract available


    February 2018
  10. KIM JM, Kwon CHD, Joh JW, Han S, et al
    ABO-incompatible Living Donor Liver Transplantation with Rituximab and Total Plasma Exchange Does Not Increase Hepatocellular Carcinoma Recurrence.
    Transplantation. 2018 Feb 28. doi: 10.1097/TP.0000000000002154.
    PubMed     Text format     Abstract available


  11. VIONNET J, Yerly P, Aubert JD, Pascual M, et al
    Management of severe portopulmonary hypertension with dual oral therapy prior to liver transplantation.
    Transplantation. 2018 Feb 26. doi: 10.1097/TP.0000000000002142.
    PubMed     Text format    


  12. CHARLTON M, Levitsky J, Aqel B, O'Grady J, et al
    International Liver Transplant Society Consensus Statement on IMMUNOSUPPRESSION IN LIVER TRANSPLANT RECIPIENTS.
    Transplantation. 2018 Feb 26. doi: 10.1097/TP.0000000000002147.
    PubMed     Text format    


  13. NAIK KB, Hawkins CM, Gill AE, Gupta NA, et al
    Clinical Efficacy of Percutaneous Transhepatic Portal Vein Angioplasty for Late-Onset Portal Vein Stenosis in Pediatric Liver Transplant Patients.
    Transplantation. 2018 Feb 20. doi: 10.1097/TP.0000000000002138.
    PubMed     Text format     Abstract available


  14. ADELMANN D, Olmos A, Liu LL, Feiner JR, et al
    Intraoperative management of liver transplant patients without the routine use of renal replacement therapy.
    Transplantation. 2018 Feb 20. doi: 10.1097/TP.0000000000002137.
    PubMed     Text format     Abstract available


  15. ANGELICO R, Gerlach UA, Gunson BK, Neil D, et al
    Severe unresolved cholestasis due to unknown aetiology leading to early allograft failure within the first 3 months of liver transplantation.
    Transplantation. 2018 Feb 20. doi: 10.1097/TP.0000000000002139.
    PubMed     Text format     Abstract available


  16. NAUGLER WE, Orloff SL
    Ganja, No Barrier for Liver Transplantation?
    Transplantation. 2018 Feb 15. doi: 10.1097/TP.0000000000002134.
    PubMed     Text format    


  17. SHIRABE K, Eguchi S, Okajima H, Hasegawa K, et al
    Current status of surgical incisions used in donors during living related liver transplantation - a nationwide survey in Japan.
    Transplantation. 2018 Feb 9. doi: 10.1097/TP.0000000000002126.
    PubMed     Text format     Abstract available


  18. SAVALE L, Duclos-Vallee JC, Sitbon O
    Outcome of portopulmonary hypertension after liver transplantation: perhaps not so optimistic.
    Transplantation. 2018 Feb 2. doi: 10.1097/TP.0000000000002112.
    PubMed     Text format    


    January 2018
  19. BHAT M, Mara K, Dierkhising R, Watt KD, et al
    Gender, Race and Disease Etiology Predict De Novo Malignancy Risk following Liver Transplantation: Insights for Future Individualized Cancer Screening Guidance.
    Transplantation. 2018 Jan 26. doi: 10.1097/TP.0000000000002113.
    PubMed     Text format     Abstract available


  20. PRZYBYSZEWSKI EM, Verna EC, Lobritto SJ, Martinez M, et al
    Durable Clinical and Immunologic Advantage of Living Donor Liver Transplantation in Children.
    Transplantation. 2018 Jan 23. doi: 10.1097/TP.0000000000002110.
    PubMed     Text format     Abstract available


  21. KINOSHITA N, Shoji K, Funaki T, Fukuda A, et al
    Safety of BCG Vaccination in Pediatric Liver Transplant Recipients.
    Transplantation. 2018 Jan 18. doi: 10.1097/TP.0000000000002103.
    PubMed     Text format    


  22. GIARD JM, Mehta N, Dodge JL, Roberts JP, et al
    Alpha-fetoprotein Slope >7.5 ng/ml/month Predicts Micro-vascular Invasion and Tumor Recurrence after Liver Transplantation for Hepatocellular Carcinoma.
    Transplantation. 2018 Jan 17. doi: 10.1097/TP.0000000000002094.
    PubMed     Text format     Abstract available


  23. BEZINOVER D, Dirkmann D, Findlay J, Guta C, et al
    Perioperative Coagulation Management in Liver Transplant Recipients.
    Transplantation. 2018 Jan 15. doi: 10.1097/TP.0000000000002092.
    PubMed     Text format     Abstract available


  24. PAMECHA V, Sandhyav R, Sinha PK, Bharathy KGS, et al
    Antegrade Arterial and Portal Flushing Versus Portal Flushing Only for Right Lobe Live Donor Liver Transplantation - A Randomized Control Trial.
    Transplantation. 2018 Jan 12. doi: 10.1097/TP.0000000000002088.
    PubMed     Text format     Abstract available


  25. KALISVAART M, Schlegel A, Umbro I, de Haan JE, et al
    The impact of combined warm ischemia time on development of acute kidney injury in donation after circulatory death liver transplantation: Stay within the golden hour.
    Transplantation. 2018 Jan 11. doi: 10.1097/TP.0000000000002085.
    PubMed     Text format     Abstract available


  26. MANDELL MS, Kay J
    High-sensitivity Troponins in Liver Transplantation: How Will They Change Our Practice?
    Transplantation. 2018 Jan 11. doi: 10.1097/TP.0000000000002067.
    PubMed     Text format    


  27. YAO S, Yagi S, Uozumi R, Iida T, et al
    A high portal venous pressure gradient increases gut-related bacteremia and consequent early mortality after living donor liver transplantation.
    Transplantation. 2018 Jan 10. doi: 10.1097/TP.0000000000002047.
    PubMed     Text format     Abstract available


  28. SADLER EM, Mehta N, Bhat M, Ghanekar A, et al
    Liver transplantation for NASH-related hepatocellular carcinoma versus non-NASH etiologies of hepatocellular carcinoma.
    Transplantation. 2018 Jan 10. doi: 10.1097/TP.0000000000002043.
    PubMed     Text format     Abstract available


  29. KOTWANI P, Saxena V, Dodge JL, Roberts J, et al
    History of marijuana use does not affect outcomes on the liver transplant waitlist.
    Transplantation. 2018 Jan 10. doi: 10.1097/TP.0000000000002045.
    PubMed     Text format     Abstract available


  30. RAYAR M, Tron C, Jezequel C, Beaurepaire JM, et al
    High intrapatient variability of tacrolimus exposure in the early period after liver transplantation is associated with poorer outcomes.
    Transplantation. 2018 Jan 8. doi: 10.1097/TP.0000000000002052.
    PubMed     Text format     Abstract available


  31. CULLARO G, Pisa JF, Brown RS Jr, Wagener G, et al
    Early Postoperative Neutrophil Gelatinase Associated Lipocalin Predicts the Development of Chronic Kidney Disease Following Liver Transplantation.
    Transplantation. 2018 Jan 3. doi: 10.1097/TP.0000000000002075.
    PubMed     Text format     Abstract available


  32. PARK J, Lee SH, Han S, Kim KY, et al
    Elevated High-Sensitivity Troponin I During Living Donor Liver Transplantation is Associated With Postoperative Adverse Outcomes.
    Transplantation. 2018 Jan 2. doi: 10.1097/TP.0000000000002068.
    PubMed     Text format     Abstract available


  33. GIRETTI G, Barbier L, Bucur P, Marques F, et al
    Recipient Selection for Optimal Utilization of Discarded Grafts in Liver Transplantation.
    Transplantation. 2018 Jan 2. doi: 10.1097/TP.0000000000002069.
    PubMed     Text format     Abstract available


    December 2017
  34. THULUVATH PJ, Hanish S, Savva Y
    Liver Transplantation in Cryptogenic Cirrhosis: Outcome comparisons between NASH, Alcoholic and AIH cirrhosis.
    Transplantation. 2017 Dec 5. doi: 10.1097/TP.0000000000002030.
    PubMed     Text format     Abstract available


  35. MORATH C, Opelz G, Dohler B, Zeier M, et al
    Influence of Blood Pressure and Calcineurin Inhibitors on Kidney Function After Heart or Liver Transplantation.
    Transplantation. 2017 Dec 5. doi: 10.1097/TP.0000000000002023.
    PubMed     Text format     Abstract available


  36. LIU AW, Jutivorakool K, Fisher CE, Rakita RM, et al
    Comparison of Preemptive Therapy and Antiviral Prophylaxis for Prevention of Cytomegalovirus in Seropositive Liver Transplant Recipients.
    Transplantation. 2017 Dec 5. doi: 10.1097/TP.0000000000002029.
    PubMed     Text format     Abstract available


    November 2017
  37. PUCHADES L, Chau S, Dodson JA, Mohamad Y, et al
    Association of Cardiac Abnormalities to the Frail Phenotype in Cirrhotic Patients on the Waitlist: From the Functional Assessment in Liver Transplantation (FrAILT) Study.
    Transplantation. 2017 Nov 20. doi: 10.1097/TP.0000000000002025.
    PubMed     Text format     Abstract available


  38. GALLAGHER TK, Thomas KA, Ladner DP, Ganger D, et al
    Incidence and Risk Factors of Intracranial Hemorrhage in Liver Transplant Recipients.
    Transplantation. 2017 Nov 17. doi: 10.1097/TP.0000000000002005.
    PubMed     Text format     Abstract available


  39. DECUYPERE JP, Ceulemans LJ, Wylin T, Martinet W, et al
    Plasmatic Villin 1 Is a Novel In Vivo Marker of Proximal Tubular Cell Injury During Renal Ischemia-Reperfusion.
    Transplantation. 2017;101:e330-e336.
    PubMed     Text format     Abstract available


  40. LI CX, Man K, Lo CM
    The Impact of Liver Graft Injury on Cancer Recurrence Posttransplantation.
    Transplantation. 2017;101:2665-2670.
    PubMed     Text format     Abstract available


  41. GREY ST, Issa F
    The 2017 Transplantation Awards: Recognizing a Landmark Clinical Trial and a Basic Science Discovery With Far-Reaching Implications.
    Transplantation. 2017;101:2655-2656.
    PubMed     Text format    


  42. ASBERG A, Robertsen I, Midtvedt K
    How to Report and Interpret Bioequivalence Data in Solid Organ Transplant Recipients.
    Transplantation. 2017;101:e347.
    PubMed     Text format    


    October 2017
  43. REYMOND M, Barbier L, Salame E, Besh C, et al
    Does Portopulmonary Hypertension Impede Liver Transplantation in Cirrhotic Patients? A French Multicentric Retrospective Study.
    Transplantation. 2017 Oct 26. doi: 10.1097/TP.0000000000001981.
    PubMed     Text format     Abstract available


  44. BRYANT R RD, Rizwan R, Zafar F, Shah SA, et al
    CONTEMPORARY OUTCOMES OF COMBINED HEART-LIVER TRANSPLANT IN PATIENTS WITH CONGENITAL HEART DISEASE.
    Transplantation. 2017 Oct 26. doi: 10.1097/TP.0000000000001978.
    PubMed     Text format     Abstract available


  45. WANGE N, Anan I, Ericzon BG, Pennlert J, et al
    Atrial fibrillation and central nervous complications in liver transplanted hereditary transthyretin amyloidosis patients.
    Transplantation. 2017 Oct 11. doi: 10.1097/TP.0000000000001975.
    PubMed     Text format     Abstract available


  46. ZHU J, Chen PY, Frankel M, Selby RR, et al
    Contemporary Policies Regarding Alcohol and Marijuana use Among Liver Transplant Programs in the United States.
    Transplantation. 2017 Oct 10. doi: 10.1097/TP.0000000000001969.
    PubMed     Text format     Abstract available


  47. BOLIA R, Shankar S, Herd L, Hardikar W, et al
    Rhesus Alloimunization Occurs After Rh Incompatible Liver Transplantation in Children.
    Transplantation. 2017 Oct 10. doi: 10.1097/TP.0000000000001976.
    PubMed     Text format    


  48. JUNG DH, Moon SH, Park SJ, Kim EJ, et al
    Angiogenesis in the Transplanted Donor Graft after Living-Donor Liver Transplantation.
    Transplantation. 2017 Oct 5. doi: 10.1097/TP.0000000000001972.
    PubMed     Text format     Abstract available


  49. SPENGLER EK, O'Leary JG, Te HS, Rogal S, et al
    Liver Transplantation in the Obese Cirrhotic Patient.
    Transplantation. 2017;101:2288-2296.
    PubMed     Text format     Abstract available


  50. O'LEARY JG, Demetris AJ, Philippe A, Freeman R, et al
    Non-HLA Antibodies Impact on C4d Staining, Stellate Cell Activation and Fibrosis in Liver Allografts.
    Transplantation. 2017;101:2399-2409.
    PubMed     Text format     Abstract available


  51. LI T, Lee W, Hara H, Long C, et al
    An Investigation of Extracellular Histones in Pig-To-Baboon Organ Xenotransplantation.
    Transplantation. 2017;101:2330-2339.
    PubMed     Text format     Abstract available


    September 2017
  52. WONG LL, Truong HP, Seto T, Lacar L, et al
    Marked decrease in urgent listing for liver transplantation over time: evolution of characteristics and outcomes of Status-1 liver transplantation.
    Transplantation. 2017 Sep 29. doi: 10.1097/TP.0000000000001967.
    PubMed     Text format     Abstract available


  53. OKAMURA Y, Yagi S, Sato T, Hata K, et al
    Coexistence of Bilirubin >/=10 mg/dL and Prothrombin Time-International Normalized Ratio >/=1.6 on Day 7: A Strong Predictor of Early Graft Loss after Living Donor Liver Transplantation.
    Transplantation. 2017 Sep 29. doi: 10.1097/TP.0000000000001959.
    PubMed     Text format     Abstract available


  54. YAMAMOTO H, Uchida K, Kawabata S, Isono K, et al
    Feasibility of Monotherapy by Rituximab Without Additional Desensitization in ABO-incompatible Living Donor Liver Transplantation.
    Transplantation. 2017 Sep 20. doi: 10.1097/TP.0000000000001956.
    PubMed     Text format     Abstract available


  55. WEICHEN Z, Feibo L, Yufu Y, Yuanxing L, et al
    Isoglycyrrhizinate magnesium enhances hepatoprotective effect of FK506 on ischemia-reperfusion injury through HMGB1 inhibition in a rat model of liver transplantation.
    Transplantation. 2017 Sep 6. doi: 10.1097/TP.0000000000001941.
    PubMed     Text format     Abstract available


  56. DEW MA, Butt Z, Liu Q, Simpson MA, et al
    Prevalence and Predictors of Patient-Reported Long-Term Mental and Physical Health After Donation in the Adult to Adult Living Donor Liver Transplantation Cohort Study (A2ALL).
    Transplantation. 2017 Sep 6. doi: 10.1097/TP.0000000000001942.
    PubMed     Text format     Abstract available


  57. SNEIDERS D, Houwen T, Pengel LHM, Polak WG, et al
    Systematic review and meta-analysis of posttransplant hepatic artery and biliary complications in patients treated with transarterial chemoembolization before liver transplantation.
    Transplantation. 2017 Sep 6. doi: 10.1097/TP.0000000000001936.
    PubMed     Text format     Abstract available


  58. RADHAKRISHNAN K, Chi A, Quan DJ, Roberts JP, et al
    Short Course of Postoperative Hepatitis B Immunoglobulin Plus Antivirals Prevents Reinfection of Liver Transplant Recipients.
    Transplantation. 2017;101:2079-2082.
    PubMed     Text format     Abstract available


  59. PARIKH ND, Marrero WJ, Sonnenday CJ, Lok AS, et al
    Population-Based Analysis and Projections of Liver Supply Under Redistricting.
    Transplantation. 2017;101:2048-2055.
    PubMed     Text format     Abstract available


  60. SALIZZONI M, Amoroso A, Lupo F, Romagnoli R, et al
    Centenarian Livers: Very Long-term Outcomes of Very Old Grafts.
    Transplantation. 2017;101:e292.
    PubMed     Text format    


    August 2017
  61. ANTONINI TM, Coilly A, Rossignol E, Fougerou-Leurent C, et al
    Sofosbuvir-based Regimens in HIV/HCV Coinfected Patients after Liver Transplantation: Results from the ANRS CO23 CUPILT Study.
    Transplantation. 2017 Aug 24. doi: 10.1097/TP.0000000000001928.
    PubMed     Text format     Abstract available


  62. CHOLANKERIL G, Li AA, Yoo ER, Ahmed A, et al
    Direct-Acting Antiviral Therapy and Improvement in Graft Survival of Hepatitis C Liver Transplant Recipients.
    Transplantation. 2017 Aug 24. doi: 10.1097/TP.0000000000001926.
    PubMed     Text format    


  63. GARCIA CR, Acosta LF, Mei X, Berger J, et al
    Liver Transplantation for the Treatment of Complicated Iatrogenic Biliary Injuries: A National Review from the UNOS Dataset.
    Transplantation. 2017 Aug 22. doi: 10.1097/TP.0000000000001922.
    PubMed     Text format     Abstract available


  64. CHARLTON M, Rinella M, Patel D, McCague K, et al
    Everolimus is Associated With Less Weight Gain Than Tacrolimus 2 Years Following Liver Transplantation: Results of a Randomized Multicenter Study.
    Transplantation. 2017 Aug 15. doi: 10.1097/TP.0000000000001913.
    PubMed     Text format     Abstract available


  65. ABAALKHAIL F, Elsiesy H, Elbeshbeshy H, Shawkat M, et al
    Treatment of Patients With Hepatitis C Virus infection (Genotype 4) With Ledipasvir-Sofosbuvir in the Liver Transplant Setting.
    Transplantation. 2017 Aug 9. doi: 10.1097/TP.0000000000001907.
    PubMed     Text format     Abstract available


  66. JOCHMANS I, Fieuws S, Monbaliu D, Pirenne J, et al
    "Model for Early Allograft Function" Outperforms "Early Allograft Dysfunction" as a Predictor of Transplant Survival.
    Transplantation. 2017;101:e258-e264.
    PubMed     Text format     Abstract available


  67. DOSHI SD, Bittermann T, Schiano TD, Goldberg DS, et al
    Waitlisted Candidates With Polycystic Liver Disease Are More Likely to be Transplanted Than Those With Chronic Liver Failure.
    Transplantation. 2017;101:1838-1844.
    PubMed     Text format     Abstract available


  68. ICHAI P, Laurent-Bellue A, Saliba F, Moreau D, et al
    Acute Liver Failure/Injury Related to Drug Reaction With Eosinophilia and Systemic Symptoms: Outcomes and Prognostic Factors.
    Transplantation. 2017;101:1830-1837.
    PubMed     Text format     Abstract available


    July 2017
  69. BOYLAN JM, Francois-Vaughan H, Gruppuso PA, Sanders JA, et al
    Engraftment and Repopulation Potential of Late Gestation Fetal Rat Hepatocytes.
    Transplantation. 2017 Jul 27. doi: 10.1097/TP.0000000000001882.
    PubMed     Text format     Abstract available


  70. BOWRING MG, Ruck JM, Haugen CE, Massie AB, et al
    Deceased-donor liver size and the sex-based disparity in liver transplantation.
    Transplantation. 2017 Jul 21. doi: 10.1097/TP.0000000000001898.
    PubMed     Text format    


  71. FUNG J, Wong T, Chok K, Chan A, et al
    Oral nucleos(t)ide Analogs Alone After Liver Transplantation in Chronic Hepatitis B with Preexisting rt204 Mutation.
    Transplantation. 2017 Jul 21. doi: 10.1097/TP.0000000000001883.
    PubMed     Text format     Abstract available


  72. HAFEEZ BHATTI AB, Saud Dar F
    Living Donor Liver Transplantation in Pakistan.
    Transplantation. 2017;101:1507-1508.
    PubMed     Text format    


  73. DUBROCK HM, Goldberg DS, Sussman NL, Bartolome SD, et al
    Predictors of Waitlist Mortality in Portopulmonary Hypertension.
    Transplantation. 2017;101:1609-1615.
    PubMed     Text format     Abstract available


  74. TAKAHARA T, Wakabayashi G, Nitta H, Hasegawa Y, et al
    The First Comparative Study of the Perioperative Outcomes Between Pure Laparoscopic Donor Hepatectomy and Laparoscopy-Assisted Donor Hepatectomy in a Single Institution.
    Transplantation. 2017;101:1628-1636.
    PubMed     Text format     Abstract available


  75. JOCHMANS I, van Rosmalen M, Pirenne J, Samuel U, et al
    Adult Liver Allocation in Eurotransplant.
    Transplantation. 2017;101:1542-1550.
    PubMed     Text format     Abstract available


  76. JIMENEZ-ROMERO LC, Caso Maestro O, Cambra Molero F, Manrique Municio A, et al
    Octogenarian Liver Grafts Reaching Centennial Age After Transplantation.
    Transplantation. 2017;101:e218-e219.
    PubMed     Text format    


  77. DE CARLIS R, Lauterio A, Ferla F, Di Sandro S, et al
    Hypothermic Machine Perfusion of Liver Grafts Can Safely Extend Cold Ischemia for Up to 20 Hours in Cases of Necessity.
    Transplantation. 2017;101:e223-e224.
    PubMed     Text format    


    June 2017
  78. KIM PT, Klintmalm GB
    Authors' Reply: Does low Hepatic Artery Flow Increase Rate of Biliary Strictures in Deceased Donor Liver Transplantation?
    Transplantation. 2017 Jun 21. doi: 10.1097/TP.0000000000001855.
    PubMed     Text format    


  79. YI Z, Mayorga ME, Orman ES, Wheeler SB, et al
    Trends in Characteristics of Patients Listed for Liver Transplantation Will Lead to Higher Rates of Waitlist Removal Due to Clinical Deterioration.
    Transplantation. 2017 Jun 20. doi: 10.1097/TP.0000000000001851.
    PubMed     Text format     Abstract available


    May 2017
  80. EMOND JC, Goodrich NP, Pomposelli JJ, Baker TB, et al
    Hepatic hemodynamics and portal flow modulation: The A2ALL experience.
    Transplantation. 2017 May 17. doi: 10.1097/TP.0000000000001823.
    PubMed     Text format     Abstract available


  81. KENSINGER CD, Feurer ID, Karp SJ
    An Outcome-Based Approach to Assign MELD Exception Points for Patients With Hepatocellular Cancer.
    Transplantation. 2017 May 4. doi: 10.1097/TP.0000000000001812.
    PubMed     Text format     Abstract available



  82. Early Introduction of Subcutaneous Hepatitis B Immunoglobulin Following Liver Transplantation for Hepatitis B Virus Infection: A Prospective, Multicenter Study: Erratum.
    Transplantation. 2017;101:e193.
    PubMed     Text format    


  83. TERRAULT NA, Berenguer M, Strasser SI, Gadano A, et al
    International Liver Transplantation Society Consensus Statement on Hepatitis C Management in Liver Transplant Recipients.
    Transplantation. 2017;101:956-967.
    PubMed     Text format    


  84. TERRAULT NA, McCaughan GW, Curry MP, Gane E, et al
    International Liver Transplantation Society Consensus Statement on Hepatitis C Management in Liver Transplant Candidates.
    Transplantation. 2017;101:945-955.
    PubMed     Text format    


  85. MILLER CM, Quintini C, Dhawan A, Durand F, et al
    The International Liver Transplantation Society Living Donor Liver Transplant Recipient Guideline.
    Transplantation. 2017;101:938-944.
    PubMed     Text format     Abstract available


  86. CHENG XS, Stedman MR, Chertow GM, Kim WR, et al
    Utility in Treating Kidney Failure in End-Stage Liver Disease With Simultaneous Liver-Kidney Transplantation.
    Transplantation. 2017;101:1111-1119.
    PubMed     Text format     Abstract available


  87. WATSON CJE, Kosmoliaptsis V, Randle LV, Gimson AE, et al
    Normothermic Perfusion in the Assessment and Preservation of Declined Livers Before Transplantation: Hyperoxia and Vasoplegia-Important Lessons From the First 12 Cases.
    Transplantation. 2017;101:1084-1098.
    PubMed     Text format     Abstract available


  88. TAPPER EB, Afdhal NH, Curry MP
    Before or After Transplantation? A Review of the Cost Effectiveness of Treating Waitlisted Patients With Hepatitis C.
    Transplantation. 2017;101:933-937.
    PubMed     Text format     Abstract available


  89. SONNERBORG IV, Hoglund P, Nordstrom J, Wikman A, et al
    Severe Transplantation-Mediated Alloimmune Thrombocytopenia in 2 Recipients of Organs From the Same Donor.
    Transplantation. 2017;101:e190-e192.
    PubMed     Text format    


    April 2017
  90. O'LEARY JG, Smith C, Cai J, Hart B, et al
    Chronic AMR in Liver Transplant: Validation of the 1-Year cAMR score's Ability to Determine Long-Term Outcome.
    Transplantation. 2017 Apr 27. doi: 10.1097/TP.0000000000001802.
    PubMed     Text format     Abstract available


  91. DE BOER JD, Blok JJ, Braat AE
    Graft Quality and Prediction of Outcome After Liver Transplantation.
    Transplantation. 2017 Apr 18. doi: 10.1097/TP.0000000000001781.
    PubMed     Text format    


  92. COMPAGNON P, Levesque E, Hentati H, Disabato M, et al
    An Oxygenated and Transportable Machine Perfusion System Fully Rescues Liver Grafts Exposed to Lethal Ischemic Damage in a Pig Model of DCD Liver Transplantation.
    Transplantation. 2017 Apr 11. doi: 10.1097/TP.0000000000001764.
    PubMed     Text format     Abstract available


  93. MAZZOLA A, Minh MT, Charlotte F, Hdjii A, et al
    Chronic hepatitis E viral infection after liver transplantation: a regression of fibrosis following antiviral therapy.
    Transplantation. 2017 Apr 4. doi: 10.1097/TP.0000000000001766.
    PubMed     Text format     Abstract available


  94. MARTIN MT, Koppe S
    Elbasvir/Grazoprevir Use in Postliver Transplantation Patients on Hemodialysis.
    Transplantation. 2017 Apr 3. doi: 10.1097/TP.0000000000001758.
    PubMed     Text format     Abstract available


  95. NEUBERGER JM, Bechstein WO, Kuypers DR, Burra P, et al
    Practical Recommendations for Long-term Management of Modifiable Risks in Kidney and Liver Transplant Recipients: A Guidance Report and Clinical Checklist by the Consensus on Managing Modifiable Risk in Transplantation (COMMIT) Group.
    Transplantation. 2017;101.
    PubMed     Text format     Abstract available


  96. OLIVER JB, Marcus AF, Paster M, Nespral J, et al
    Organ Procurement Organization Survey of Practices and Beliefs Regarding Prerecovery Percutaneous Liver Biopsy in Donation After Neurologic Determination of Death.
    Transplantation. 2017;101:821-825.
    PubMed     Text format     Abstract available


  97. COLLETT D, Friend PJ, Watson CJ
    Factors Associated With Short- and Long-term Liver Graft Survival in the United Kingdom: Development of a UK Donor Liver Index.
    Transplantation. 2017;101:786-792.
    PubMed     Text format     Abstract available


    March 2017
  98. MEHTA N, Heimbach J, Lee D, Dodge JL, et al
    Wait Time of < 6 and > 18 Months Predicts Hepatocellular Carcinoma Recurrence after Liver Transplantation: Proposing a Wait Time "Sweet Spot".
    Transplantation. 2017 Mar 28. doi: 10.1097/TP.0000000000001752.
    PubMed     Text format     Abstract available


  99. SHENG M, Lin Y, Weng Y, Xu R, et al
    Predictive Value of Intraoperative Troponin I Elevation in Pediatric Living Donor Liver Transplant Recipients With Biliary Atresia.
    Transplantation. 2017 Mar 18. doi: 10.1097/TP.0000000000001732.
    PubMed     Text format     Abstract available


  100. PARLAK E, Koksal AS, Eminler AT, Toka B, et al
    Treatment of Biliary Stricture After Live Donor Liver Transplantation With Combined Metal and Plastic Stent Insertion: A Feasibility and Safety Study.
    Transplantation. 2017 Mar 18. doi: 10.1097/TP.0000000000001734.
    PubMed     Text format     Abstract available


  101. NEKRASOV V, Matsuoka L, Kaur N, Pita A, et al
    Improvement in the Outcomes of MELD >/= 40 Liver Transplantation: An Analysis of 207 Consecutive Transplants in a Highly Competitive DSA.
    Transplantation. 2017 Mar 18. doi: 10.1097/TP.0000000000001738.
    PubMed     Text format     Abstract available


  102. KONERMAN MA, Fritze D, Weinberg RL, Sonnenday CJ, et al
    Incidence of and Risk Assessment for Adverse Cardiovascular Outcomes Following Liver Transplantation: A Systematic Review.
    Transplantation. 2017 Mar 15. doi: 10.1097/TP.0000000000001710.
    PubMed     Text format     Abstract available


  103. BHATI C, Idowu MO, Sanyal AJ, Rivera M, et al
    Long Term Outcomes in Patients Undergoing Liver Transplantation for Nonalcoholic Steatohepatitis Related Cirrhosis.
    Transplantation. 2017 Mar 15. doi: 10.1097/TP.0000000000001709.
    PubMed     Text format     Abstract available


  104. MURALI AR, Patil S, Phillips KT, Voigt M, et al
    Locoregional Therapy with Curative Intent versus Primary Liver Transplant for Hepatocellular Carcinoma: Systematic Review and Meta-analysis.
    Transplantation. 2017 Mar 10. doi: 10.1097/TP.0000000000001730.
    PubMed     Text format     Abstract available


  105. MOUCHLI MA, Singh S, Loftus EV Jr, Boardman L, et al
    Risk Factors and Outcomes of De novo Cancers (Excluding Nonmelanoma Skin Cancer) after Liver Transplantation for Primary Sclerosing Cholangitis.
    Transplantation. 2017 Mar 8. doi: 10.1097/TP.0000000000001725.
    PubMed     Text format     Abstract available


  106. AULBERT W, Kobbe R, Breuer C, Briem-Richter A, et al
    Hypereosinophilic Syndrome After Liver Transplantation - a Case Report and a Review of the Literature.
    Transplantation. 2017 Mar 4. doi: 10.1097/TP.0000000000001721.
    PubMed     Text format     Abstract available


  107. SIMONETTA F, Pradier A, Masouridi-Levrat S, van Delden C, et al
    Torque Teno Virus Load and Acute Rejection after Orthotopic Liver Transplantation.
    Transplantation. 2017 Mar 4. doi: 10.1097/TP.0000000000001723.
    PubMed     Text format    


  108. LAI Q, Feys E, Karam V, Adam R, et al
    Hepatic Epithelioid Hemangioendothelioma and Adult Liver Transplantation: Proposal for a Prognostic Score Based on the Analysis of the ELTR-ELITA Registry.
    Transplantation. 2017;101:555-564.
    PubMed     Text format     Abstract available


  109. TERRAULT N, Berenguer M, Strasser S, Gadano A, et al
    International Liver Transplant Society Consensus Statement on HEPATITIS C MANAGEMENT IN LIVER TRANSPLANT RECIPIENTS.
    Transplantation. 2017 Mar 1. doi: 10.1097/TP.0000000000001704.
    PubMed     Text format    


  110. TERRAULT NA, McCaughan GW, Curry MP, Gane E, et al
    International Liver Transplant Society Consensus Statement on HEPATITIS C MANAGEMENT IN LIVER TRANSPLANT CANDIDATES.
    Transplantation. 2017 Mar 1. doi: 10.1097/TP.0000000000001708.
    PubMed     Text format    


  111. ARONSOHN A
    Timing is Everything: Managing Hepatitis C in Liver Transplant Candidates.
    Transplantation. 2017 Mar 1. doi: 10.1097/TP.0000000000001703.
    PubMed     Text format    


    February 2017
  112. BRUINSMA BG, Avruch JH, Sridharan GV, Weeder PD, et al
    Peritransplant energy changes and their correlation to outcome after human liver transplantation.
    Transplantation. 2017 Feb 23. doi: 10.1097/TP.0000000000001699.
    PubMed     Text format     Abstract available


  113. EBEL NH, Hsu EK, Berry K, Horslen SP, et al
    Disparities in waitlist and posttransplantation outcomes in liver transplant registrants and recipients 18-24 years old: analysis of the UNOS database.
    Transplantation. 2017 Feb 22. doi: 10.1097/TP.0000000000001689.
    PubMed     Text format     Abstract available


  114. VERNA EC, Brown RS Jr
    HCV Antiviral Therapy In Liver Transplant Candidates and Recipients with Renal Insufficiency.
    Transplantation. 2017 Feb 16. doi: 10.1097/TP.0000000000001688.
    PubMed     Text format     Abstract available


  115. XIE Y, Wu Y, Xin K, Wang JJ, et al
    Delayed Donor Bone Marrow Infusion Induces Liver Transplant Tolerance.
    Transplantation. 2017 Feb 10. doi: 10.1097/TP.0000000000001684.
    PubMed     Text format     Abstract available


  116. BADENOCH A, Sharma A, Gower S, Selzner M, et al
    The Effectiveness and Safety of Tranexamic Acid in Orthotopic Liver Transplantation Clinical Practice: A Propensity Score Matched Cohort Study.
    Transplantation. 2017 Feb 10. doi: 10.1097/TP.0000000000001682.
    PubMed     Text format     Abstract available


  117. WADSTROM J, Ericzon BG, Halloran PF, Bechstein WO, et al
    Advancing Transplantation: New Questions, New Possibilities in Kidney and Liver Transplantation.
    Transplantation. 2017;101 Suppl 2S:S1-S41.
    PubMed     Text format    


  118. CHAPMAN WC, Brown RS Jr, Chavin KD, Sudan D, et al
    Effect of Early Everolimus-Facilitated Reduction of Tacrolimus on Efficacy and Renal Function in De Novo Liver Transplant Recipients: 24-Month Results for the North American Subpopulation.
    Transplantation. 2017;101:341-349.
    PubMed     Text format     Abstract available


  119. LERUT J
    Jan Lerut, MD, PhD: Professor Emeritus of Surgery, Director of the Starzl Abdominal Transplant Unit, University Hospitals Saint Luc and UCL Transplant Centre in Brussels; and Past President, European Society of Organ Transplantation and International
    Transplantation. 2017;101:223-226.
    PubMed     Text format    


  120. KARANGWA SA, Burlage LC, Adelmeijer J, Karimian N, et al
    Activation of Fibrinolysis, But Not Coagulation, During End-Ischemic Ex Situ Normothermic Machine Perfusion of Human Donor Livers.
    Transplantation. 2017;101:e42-e48.
    PubMed     Text format     Abstract available


  121. KILAMBI V, Mehrotra S
    Improving Liver Allocation Using Optimized Neighborhoods.
    Transplantation. 2017;101:350-359.
    PubMed     Text format     Abstract available


  122. PALUMBO T, Nakamura K, Lassman C, Kidani Y, et al
    Bruton Tyrosine Kinase Inhibition Attenuates Liver Damage in a Mouse Warm Ischemia and Reperfusion Model.
    Transplantation. 2017;101:322-331.
    PubMed     Text format     Abstract available


  123. REDDY MS, Rajalingam R, Rela M
    Revisiting APOLT for Metabolic Liver Disease: A New Look at an Old Idea.
    Transplantation. 2017;101:260-266.
    PubMed     Text format     Abstract available


  124. CHOUDHURY RA, Reese PP, Goldberg DS, Bloom RD, et al
    A Paired Kidney Analysis of Multiorgan Transplantation: Implications for Allograft Survival.
    Transplantation. 2017;101:368-376.
    PubMed     Text format     Abstract available


  125. RATHNASAMY MUTHUSAMY AS, Friend PJ, Dor FJ, Crane JS, et al
    DCD Pancreas Transplantation Meta-Analysis: Ethical and Technical Considerations.
    Transplantation. 2017;101:e57.
    PubMed     Text format    


    January 2017
  126. BITTERMANN T, Goldberg DS, Bauer CM, Khungar V, et al
    Characterizing the risk of false-positive hepatocellular carcinoma in recipients transplanted with T2 MELD exceptions.
    Transplantation. 2017 Jan 25. doi: 10.1097/TP.0000000000001660.
    PubMed     Text format     Abstract available


  127. HIRATA Y, Yoshizawa A, Egawa H, Ueda D, et al
    Impact of Antibodies that React with Liver Tissue and Donor-specific anti-HLA Antibodies in Pediatric Idiopathic Posttransplantation Hepatitis.
    Transplantation. 2017 Jan 23. doi: 10.1097/TP.0000000000001653.
    PubMed     Text format     Abstract available


  128. GOLDBERG DS, Karp SJ, McCauley ME, Markmann JF, et al
    Interpreting Outcomes in DCDD Liver Transplantation: First Report of the Multi-Center IDOL Consortium.
    Transplantation. 2017 Jan 21. doi: 10.1097/TP.0000000000001656.
    PubMed     Text format     Abstract available


  129. SATAPATHY SK, Vanatta JM, Helmick R, Flowers A, et al
    Outcome of Liver Transplant Recipients With Revascularized Coronary Artery Disease: A Comparative Analysis With and Without Cardiovascular Risk Factors.
    Transplantation. 2017 Jan 17. doi: 10.1097/TP.0000000000001647.
    PubMed     Text format     Abstract available


  130. KIM KH, Kang SH, Jung DH, Yoon YI, et al
    Initial outcomes of pure laparoscopic living donor right hepatectomy in an experienced adult living donor liver transplant center.
    Transplantation. 2017 Jan 9. doi: 10.1097/TP.0000000000001637.
    PubMed     Text format     Abstract available


  131. VINAIXA C, Strasser SI, Berenguer M
    DISEASE REVERSIBILITY IN PATIENTS WITH POSTHEPATITIS C CIRRHOSIS: IS THE POINT OF NO RETURN THE SAME BEFORE AND AFTER LIVER TRANSPLANTATION? A REVIEW.
    Transplantation. 2017 Jan 6. doi: 10.1097/TP.0000000000001633.
    PubMed     Text format     Abstract available



  132. Adherence to and Acceptance of Once-Daily Tacrolimus After Kidney and Liver Transplant: Results From OSIRIS, a French Observational Study: Erratum.
    Transplantation. 2017;101:e40-e41.
    PubMed     Text format    



  133. Impact of Cytomegalovirus Infection on Severe Hepatitis C Recurrence in Patients Undergoing Liver Transplantation: Erratum.
    Transplantation. 2017;101:e40.
    PubMed     Text format    


  134. LIU D, Chan AC, Fong DY, Lo CM, et al
    Evidence-Based Surveillance Imaging Schedule After Liver Transplantation for Hepatocellular Carcinoma Recurrence.
    Transplantation. 2017;101:107-111.
    PubMed     Text format     Abstract available


  135. DEMARTINO ES, Cartin-Ceba R, Findlay JY, Heimbach JK, et al
    Frequency and Outcomes of Patients With Increased Mean Pulmonary Artery Pressure at the Time of Liver Transplantation.
    Transplantation. 2017;101:101-106.
    PubMed     Text format     Abstract available


  136. ONO Y, Perez-Gutierrez A, Yovchev MI, Matsubara K, et al
    Regeneration and Cell Recruitment in an Improved Heterotopic Auxiliary Partial Liver Transplantation Model in the Rat.
    Transplantation. 2017;101:92-100.
    PubMed     Text format     Abstract available


  137. RICH N, Tanriover B, Singal AG, Marrero JA, et al
    Outcomes of Simultaneous Liver Kidney Transplantation in Patients With Hepatocellular Carcinoma.
    Transplantation. 2017;101:e12-e19.
    PubMed     Text format     Abstract available


  138. ASHOKKUMAR C, Soltys K, Mazariegos G, Bond G, et al
    Predicting Cellular Rejection With a Cell-Based Assay: Preclinical Evaluation in Children.
    Transplantation. 2017;101:131-140.
    PubMed     Text format     Abstract available


  139. KENNEDY C, Counihan A, Magee C
    Transplantation in Ireland.
    Transplantation. 2017;101:1-4.
    PubMed     Text format    


    December 2016
  140. FREIRE MP, Oshiro IC, Pierrotti LC, Bonazzi PR, et al
    Carbapenem-Resistant Enterobacteriaceae Acquired before Liver Transplantation: Impact on Recipient Outcomes.
    Transplantation. 2016 Dec 22. doi: 10.1097/TP.0000000000001620.
    PubMed     Text format     Abstract available


  141. DIAZ GC, Zerillo J, Singhal A, Hibi T, et al
    Report of the 22nd Annual Congress of the International Liver Transplantation Society.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  142. KIM PT, Fernandez H, Gupta A, Saracino G, et al
    Low measured hepatic artery flow increases rate of biliary strictures in deceased donor liver transplantation: An age dependent phenomenon.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  143. LAU L, Kankanige Y, Rubinstein B, Jones R, et al
    Machine-Learning Algorithms Predict Graft Failure Following Liver Transplantation.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  144. HAMAGUCHI Y, Kaido T, Okumura S, Kobayashi A, et al
    Impact of skeletal muscle mass index, intramuscular adipose tissue content, and visceral to subcutaneous adipose tissue area ratio on early mortality of living donor liver transplantation.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  145. LAI Q, Feys E, Karam V, Adam R, et al
    HEPATIC EPITHELIOID HEMANGIO-ENDOTHELIOMA AND ADULT LIVER TRANSPLANTATION: PROPOSAL FOR A PROGNOSTIC SCORE BASED ON THE ANALYSIS OF THE ELTR-ELITA REGISTRY.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  146. SALAZAR J, Saxena V, Kahn JG, Roberts JP, et al
    Cost-Effectiveness of Direct-Acting Anti-viral Treatment in Hepatitis C-infected Liver Transplant Candidates with Compensated Cirrhosis and Hepatocellular Carcinoma.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  147. CROOME KP, Lee DD, Keaveny AP, Taner CB, et al
    Improving National Results in Liver Transplantation Using Grafts From Donation After Cardiac Death Donors.
    Transplantation. 2016;100:2640-2647.
    PubMed     Text format     Abstract available


  148. CARRILLO CF, Crespo G, de la Revilla J, Castells L, et al
    Successful continuation of HCV treatment following liver transplantation.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  149. MILLER CM, Quintini C, Dhawan A, Durand F, et al
    The International Liver Transplant Society (ILTS) Living Donor Liver Transplant Recipient Guideline.
    Transplantation. 2016.
    PubMed     Text format    


    November 2016
  150. BARBIER L, Cesaretti M, Dondero F, Cauchy F, et al
    Liver Transplantation With Older Donors: A Comparison With Younger Donors in a Context of Organ Shortage.
    Transplantation. 2016;100:2410-2415.
    PubMed     Text format     Abstract available


  151. ZAHR ELDEEN F, Roll GR, Derosas C, Rao R, et al
    Preoperative Thromboelastography as a Sensitive Tool Predicting Those at Risk of Developing Early Hepatic Artery Thrombosis After Adult Liver Transplantation.
    Transplantation. 2016;100:2382-2390.
    PubMed     Text format     Abstract available


  152. KRAWCZYK M, Grat M, Adam R, Polak WG, et al
    Liver Transplantation for Hepatic Trauma: A Study From the European Liver Transplant Registry.
    Transplantation. 2016;100:2372-2381.
    PubMed     Text format     Abstract available


  153. MURALI AR, Romero-Marrero C, Miller C, Aucejo F, et al
    Predictors of Successful Downstaging of Hepatocellular Carcinoma Outside Milan Criteria.
    Transplantation. 2016;100:2391-2397.
    PubMed     Text format     Abstract available


    October 2016
  154. ROTELLAR F, Pardo F, Benito A, Zozaya G, et al
    Totally laparoscopic right hepatectomy for living donor liver transplantation. Analysis of a preliminary experience on 5 consecutive cases.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  155. NICASTRO E, Giovannozzi S, Stroppa P, Callegaro AP, et al
    Effectiveness of preemptive therapy for Cytomegalovirus disease in pediatric liver transplantation.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  156. IKEGAMI T, Shimagaki T, Kawasaki J, Yoshizumi T, et al
    Eversion technique to prevent biliary stricture after living donor liver transplantation in the universal minimal hilar dissection era.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  157. ALVAREZ-SOTOMAYOR D, Satorres C, Rodriguez-Medina B, Herrero I, et al
    Controlling Diabetes After Liver Transplantation: Room for Improvement.
    Transplantation. 2016;100:e66-e73.
    PubMed     Text format     Abstract available


  158. DEBETTE-GRATIEN M, Woillard JB, Picard N, Sebagh M, et al
    Influence of Donor and Recipient CYP3A4, CYP3A5, and ABCB1 Genotypes on Clinical Outcomes and Nephrotoxicity in Liver Transplant Recipients.
    Transplantation. 2016;100:2129-2137.
    PubMed     Text format     Abstract available


  159. CASSUTO E, Pageaux GP, Cantarovich D, Rostaing L, et al
    Adherence to and Acceptance of Once-Daily Tacrolimus After Kidney and Liver Transplant: Results From OSIRIS, a French Observational Study.
    Transplantation. 2016;100:2099-2106.
    PubMed     Text format     Abstract available


    September 2016
  160. CROOME KP, Lee DD, Keaveny AP, Burcin Taner C, et al
    IMPROVING NATIONAL RESULTS IN LIVER TRANSPLANTATION USING GRAFTS FROM DONATION AFTER CARDIAC DEATH DONORS.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  161. ELFEKI M, Abou Mrad R, Modaresi Esfeh J, Zein N, et al
    Sofosbuvir/Ledipasvir without Ribavirin Achieved High Sustained Virologic Response for Hepatitis C Recurrence after Liver Transplantation: Two-Center Experience.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


    August 2016
  162. SCHLANSKY B, Naugler WE, Orloff SL, Enestvedt CK, et al
    Higher Mortality and Survival Benefit in Obese Patients Awaiting Liver Transplantation.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  163. POMPOSELLI JJ
    Hepatic Artery Thrombosis (HAT) After Liver Transplant: Not A Surgical Problem?
    Transplantation. 2016.
    PubMed     Text format    


  164. MOHKAM K, Fanget F, Darnis B, Harbaoui B, et al
    Use of systemic vasodilators for the management of Doppler ultrasound arterial abnormalities after orthotopic liver transplantation.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  165. MANDELL MS, Smith AR, Dew MA, Gordon DB, et al
    Early Postoperative Pain and its Predictors in the Adult to Adult Living Donor Liver Transplantation Cohort Study (A2ALL).
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  166. DE CARLIS L, De Carlis R, Lauterio A, Di Sandro S, et al
    Sequential use of normothermic regional perfusion and hypothermic machine perfusion in donation after cardiac death liver transplantation with extended warm ischemia time.
    Transplantation. 2016.
    PubMed     Text format    


  167. DE SIMONE P, Fagiuoli S, Cescon M, De Carlis L, et al
    Use of Everolimus in Liver Transplantation: Recommendations From a Working Group.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  168. FURUICHI M, Fujiwara T, Fukuda A, Kasahara M, et al
    Fulminant hepatic failure as a risk factor for cytomegalovirus infection in children receiving preemptive therapy after living donor liver transplantation.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  169. TAPPER EB, Hughes MS, Buti M, Dufour JF, et al
    The optimal timing of hepatitis C therapy in transplant eligible patients with Child B and C Cirrhosis: A Cost-Effectiveness Analysis.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  170. CICALESE L, Shirafkan A, Jennings K, Zorzi D, et al
    Increased risk of death for patients on the waitlist for liver transplant residing at greater distance from specialized liver transplant centers in the USA.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  171. HART A, Schladt DP, Zeglin J, Pyke J, et al
    Predicting outcomes on the liver transplant waiting list in the United States: Accounting for large regional variation in organ availability and priority allocation points.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  172. HAMAGUCHI Y, Kaido T, Okumura S, Kobayashi A, et al
    Proposal of Muscle-MELD score, including muscularity, for prediction of mortality after living donor liver transplantation.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  173. MURALI AR, Chandra S, Stewart Z, Blazar BR, et al
    Graft versus Host Disease After Liver Transplantation in Adults: A Case series, Review of Literature, and an Approach to Management.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  174. SALIBA F, Rostaing L, Gugenheim J, Durand F, et al
    Corticosteroid-Sparing and Optimization of Mycophenolic Acid Exposure in Liver Transplant Recipients Receiving Mycophenolate Mofetil and Tacrolimus: A Randomized, Multicenter Study.
    Transplantation. 2016;100:1705-13.
    PubMed     Text format     Abstract available


    July 2016
  175. VIEHMAN JA, Clancy CJ, Clarke L, Shields R, et al
    Surgical site infections after liver transplantation: Emergence of multi-drug resistant bacteria and implications for prophylaxis and treatment strategies.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  176. PICHLER RH, Huskey J, Kowalewska J, Moiz A, et al
    Kidney Biopsies May Help Predict Renal Function following Liver Transplantation.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  177. GYOTEN K, Mizuno S, Kato H, Murata Y, et al
    A novel predictor of posttransplant portal hypertension in adult-to-adult living donor liver transplantation: increased estimated spleen/graft volume ratio.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  178. GOODRICH NP, Schaubel DE, Smith AR, Merion RM, et al
    National Assessment of Hospitalization Rates for Incident End Stage Renal Disease after Liver Transplantation.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  179. HAARER J, Riquelme P, Hoffmann P, Schnitzbauer A, et al
    Early Enrichment and Restitution of the Peripheral Blood Treg Pool Is Associated With Rejection-Free Stable Immunosuppression After Liver Transplantation.
    Transplantation. 2016;100:e39-40.
    PubMed     Text format    


  180. POMPOSELLI JJ, Goodrich NP, Emond JC, Humar A, et al
    Patterns of Early Allograft Dysfunction in Adult Live Donor Liver Transplantation: The A2ALL Experience.
    Transplantation. 2016;100:1490-9.
    PubMed     Text format     Abstract available


  181. KROWKA MJ, Fallon MB, Kawut SM, Fuhrmann V, et al
    International Liver Transplant Society Practice Guidelines: Diagnosis and Management of Hepatopulmonary Syndrome and Portopulmonary Hypertension.
    Transplantation. 2016;100:1440-52.
    PubMed     Text format     Abstract available


  182. SULLIVAN T, Weinberg A, Rana M, Patel G, et al
    The Epidemiology and Clinical Features of Clostridium difficile Infection in Liver Transplant Recipients.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


    June 2016
  183. FEIER FH, Seda-Neto J, da Fonseca EA, Candido HL, et al
    Analysis of Factors Associated With Biliary Complications in Children After Liver Transplantation.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  184. GEISSLER EK, Schnitzbauer AA, Schlitt HJ
    A Rebuttal Letter in Response to: Mammalian Target of Rapamycin Inhibitors Against Hepatocellular Carcinoma Recurrence After Liver Transplantation.
    Transplantation. 2016.
    PubMed     Text format    


  185. HAN S, Yang JD, Sinn DH, Ko JS, et al
    Higher Bilirubin Levels of Healthy Living Liver Donors Are Associated With Lower Posttransplant Hepatocellular Carcinoma Recurrence.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  186. HSU CC, Chen CL, Wang CC, Lin CC, et al
    Combination of FDG-PET and UCSF Criteria for Predicting HCC Recurrence After Living Donor Liver Transplantation.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  187. CHOLONGITAS E
    Mammalian Target of Rapamycin Inhibitors Against Hepatocellular Carcinoma Recurrence After Liver Transplantation.
    Transplantation. 2016.
    PubMed     Text format    


  188. NARASIMHAN G, Safwan M, Kota V, Reddy MS, et al
    Donor Outcomes in Living Donor Liver Transplantation-Analysis of 275 Donors From a Single Centre in India.
    Transplantation. 2016;100:1251-6.
    PubMed     Text format     Abstract available


  189. EMOND JC
    Live Donor Liver Transplantation: An International Perspective.
    Transplantation. 2016;100:1182-3.
    PubMed     Text format    



  190. Russell W. Strong, FRCS (Eng), FRACS, FRACDS: Pioneering Live Donor Liver Transplantation.
    Transplantation. 2016;100:1177-9.
    PubMed     Text format    


  191. WERNER JM, Schlitt HJ
    Living Donor Liver Transplantation.
    Transplantation. 2016;100:1173-4.
    PubMed     Text format    


  192. SALVALAGGIO PR, Seda Neto J, Alves JA, Fonseca EA, et al
    Consensus, Dilemmas, and Challenges in Living Donor Liver Transplantation in Latin America.
    Transplantation. 2016;100:1161-4.
    PubMed     Text format     Abstract available


  193. WANG CW, Feng S, Covinsky KE, Hayssen H, et al
    A Comparison of Muscle Function, Mass, and Quality in Liver Transplant Candidates: Results From the Functional Assessment in Liver Transplantation Study.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


    May 2016
  194. DEW MA, DiMartini AF, Ladner DP, Simpson MA, et al
    Psychosocial Outcomes 3 to 10 Years After Donation in the Adult to Adult Living Donor Liver Transplantation Cohort Study.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  195. TOMODA T, Kato H, Mizukawa S, Yabe S, et al
    Biliary Anastomotic Stricture After Adult Living Donor Liver Transplantation With Duct-to-Duct Reconstruction: Outcome After Endoscopic Treatment Including Rendezvous Procedure.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


    April 2016
  196. KUBAL C, Mangus R, Fridell J, Saxena R, et al
    Optimization of Perioperative Conditions to Prevent Ischemic Cholangiopathy in Donation After Circulatory Death Donor Liver Transplantation.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  197. GHINOLFI D, De Simone P, Tincani G, Pezzati D, et al
    Beyond the Limit: Approaching Systematic Use of Nonagenarian Donors in Liver Transplantation.
    Transplantation. 2016.
    PubMed     Text format    


  198. BRITO-COSTA A, Pereira-da-Silva L, Papoila AL, Alves M, et al
    Factors Associated With Changes in Body Composition Shortly After Orthotopic Liver Transplantation: The Potential Influence of Immunosuppressive Agents.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  199. BRAUN HJ, Dodge JL, Roll GR, Freise CE, et al
    Impact of Graft Selection on Donor and Recipient Outcomes After Living Donor Liver Transplantation.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  200. MILLER CM, Durand F, Heimbach JK, Kim-Schluger L, et al
    The International Liver Transplant Society Guidelines on Living Liver Donation.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  201. DE CARLIS L, Lauterio A, De Carlis R, Ferla F, et al
    Donation After Cardiac Death Liver Transplantation After More Than 20 Minutes of Circulatory Arrest and Normothermic Regional Perfusion.
    Transplantation. 2016;100:e21-2.
    PubMed     Text format    


  202. VITALONE MJ, Wei L, Fujiki M, Lau AH, et al
    Liver microRNA Profile of Induced Allograft Tolerance.
    Transplantation. 2016;100:781-90.
    PubMed     Text format     Abstract available


  203. MAS VR, Portilla D, Maluf DG
    Biomarkers of Transplant Tolerance: A Provisional Analysis for an Unmet Need.
    Transplantation. 2016;100:705-6.
    PubMed     Text format    


  204. REDDY MS, Shrivastav M, Kaliamoorthy I, Kota V, et al
    Safety of Live Liver Donation by Individuals With G6PD Deficiency: Initial Results and Comparative Study.
    Transplantation. 2016;100:814-8.
    PubMed     Text format     Abstract available


  205. LI AH, Lam NN, Naylor KL, Garg AX, et al
    Early Hospital Readmissions After Transplantation: Burden, Causes, and Consequences.
    Transplantation. 2016;100:713-8.
    PubMed     Text format     Abstract available


    March 2016
  206. DE SIMONE P, Romagnoli R, Tandoi F, Carrai P, et al
    Early Introduction of Subcutaneous Hepatitis B Immunoglobulin Following Liver Transplantation for Hepatitis B Virus Infection: A Prospective, Multicenter Study.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  207. CAO Y, Shahrestani S, Chew HC, Crawford M, et al
    Donation After Circulatory Death for Liver Transplantation: A Meta-Analysis on the Location of Life Support Withdrawal Affecting Outcomes.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  208. VANDEKERCKHOVE K, Coomans I, De Bruyne E, De Groote K, et al
    Evaluation of Exercise Performance, Cardiac Function, and Quality of Life in Children After Liver Transplantation.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  209. SEDA-NETO J, Antunes da Fonseca E, Pugliese R, Candido HL, et al
    Twenty Years of Experience in Pediatric Living Donor Liver Transplantation: Focus on Hepatic Artery Reconstruction, Complications and Outcomes.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  210. ADDOLORATO G, Bataller R, Burra P, DiMartini A, et al
    Liver Transplantation for Alcoholic Liver Disease.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  211. KHORSANDI SE, Yip VS, Cortes M, Jassem W, et al
    Does Donation After Cardiac Death Utilization Adversely Effect Hepatocellular Cancer Survival?
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  212. FAISAL N, Bilodeau M, Aljudaibi B, Hirsch G, et al
    Sofosbuvir-Based Antiviral Therapy Is Highly Effective In Recurrent Hepatitis C in Liver Transplant Recipients: Canadian Multicenter "Real-Life" Experience.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  213. MANAS D, Burnapp L, Andrews PA
    Summary of the British Transplantation Society UK Guidelines for Living Donor Liver Transplantation.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  214. FOSTER BJ, Dahhou M, Zhang X, Dharnidharka VR, et al
    High Risk of Liver Allograft Failure During Late Adolescence and Young Adulthood.
    Transplantation. 2016;100:577-84.
    PubMed     Text format     Abstract available


    February 2016
  215. RELA M, Reddy MS
    "Failure to Rescue" as a Novel Quality Metric in Pediatric Liver Transplantation.
    Transplantation. 2016.
    PubMed     Text format    


  216. CRAMM SL, Waits SA, Englesbe MJ, Bucuvalas JC, et al
    Failure to Rescue as a Quality Improvement Approach in Transplantation: A First Effort to Evaluate This Tool in Pediatric Liver Transplantation.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  217. LING Q, Xu X, Wang B, Li L, et al
    The Origin of New-Onset Diabetes After Liver Transplantation: Liver, Islets, or Gut?
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  218. WESTERKAMP AC, Karimian N, Matton AP, Mahboub P, et al
    Oxygenated Hypothermic Machine Perfusion After Static Cold Storage Improves Hepatobiliary Function of Extended Criteria Donor Livers.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  219. TOUSSAINT A, Weiss E, Khoy-Ear L, Janny S, et al
    Prognostic Value of Preoperative Brain Natriuretic Peptide Serum Levels in Liver Transplantation.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  220. WERNER JM, Vermehren J
    New HCV Therapies and Liver Transplantation.
    Transplantation. 2016;100:260-1.
    PubMed     Text format    


  221. SUHR OB, Larsson M, Ericzon BG, Wilczek HE, et al
    Survival After Transplantation in Patients With Mutations Other Than Val30Met: Extracts From the FAP World Transplant Registry.
    Transplantation. 2016;100:373-81.
    PubMed     Text format     Abstract available


    January 2016
  222. LIMAYE AP, La Rosa C, Longmate J, Diamond DJ, et al
    Plasma IL-10 Levels to Guide Antiviral Prophylaxis Prevention of Late-Onset Cytomegalovirus Disease, in High Risk Solid Kidney and Liver Transplant Recipients.
    Transplantation. 2016;100:210-6.
    PubMed     Text format     Abstract available


  223. POMFRET EA
    Killing Two Birds With One Stone: Antineoplastic Immunosuppression.
    Transplantation. 2016;100:14-5.
    PubMed     Text format    


  224. LEUVENINK HG
    Warming Up--Not Only Essential for Athletes?
    Transplantation. 2016;100:10-1.
    PubMed     Text format    


  225. HOYER DP, Mathe Z, Gallinat A, Canbay AC, et al
    Controlled Oxygenated Rewarming of Cold Stored Livers Prior to Transplantation: First Clinical Application of a New Concept.
    Transplantation. 2016;100:147-52.
    PubMed     Text format     Abstract available


  226. VIJGEN S, Wyss C, Meylan P, Bisig B, et al
    Fatal Outcome of Multiple Clinical Presentations of Human Herpesvirus 8-related Disease After Solid Organ Transplantation.
    Transplantation. 2016;100:134-40.
    PubMed     Text format     Abstract available


    December 2015
  227. DU H, Sheng M, Wu L, Zhang Y, et al
    Hydrogen-Rich Saline Attenuates Acute Kidney Injury After Liver Transplantation via Activating p53-Mediated Autophagy.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  228. TANIMINE N, Tanaka Y, Abe T, Piao J, et al
    Functional Behavior of NKp46-Positive Intrahepatic Natural Killer Cells Against Hepatitis C Virus Reinfection After Liver Transplantation.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  229. ABERG F, Nordin A, Toivonen L, Isoniemi H, et al
    Early Predictors of Long-term Outcomes of HCV-Negative Liver Transplant Recipients Having Survived the First Postoperative Year.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  230. DOYCHEVA I, Leise MD, Watt KD
    The Intestinal Microbiome and the Liver Transplant Recipient: What We Know and What We Need to Know.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  231. GLOVER TE, Watson CJ, Gibbs P, Bradley JA, et al
    Conversion From Calcineurin to Mammalian Target of Rapamycin Inhibitors in Liver Transplantation: A Meta-Analysis of Randomized Controlled Trials.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  232. THORSEN T, Aandahl EM, Bennet W, Olausson M, et al
    Transplantation With Livers From Deceased Donors Older Than 75 Years.
    Transplantation. 2015;99:2534-42.
    PubMed     Text format     Abstract available


    November 2015
  233. MAS V, Archer KJ, Maluf D
    The High-Risk Age Window After Pediatric Liver Transplantation: Modeling Allograft Loss Using Mathematical Tools.
    Transplantation. 2015.
    PubMed     Text format    


  234. OLMEDILLA L, Lisbona CJ, Perez-Pena JM, Lopez-Baena JA, et al
    Early Measurement of Indocyanine Green Clearance Accurately Predicts Short-Term Outcomes After Liver Transplantation.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  235. GEISSLER EK, Schnitzbauer AA, Zulke C, Lamby PE, et al
    Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma: A Randomized, Multicenter, Open-Label Phase 3 Trial.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  236. ISMAIL SY, Duerinckx N, van der Knoop MM, Timmerman L, et al
    Toward a Conceptualization of the Content of Psychosocial Screening in Living Organ Donors: An Ethical Legal Psychological Aspects of Transplantation Consensus.
    Transplantation. 2015;99:2413-21.
    PubMed     Text format     Abstract available


  237. IGARASHI Y, Onoe T, Ohdan H
    The Role of Liver Sinusoidal Endothelial Cells in Induction of Carbohydrate Reactive B Cells Tolerance Through the Programmed Death 1/Programmed Death Ligand 1 Pathway.
    Transplantation. 2015;99:2325-36.
    PubMed     Text format     Abstract available


  238. MARIANTE-NETO G, Brandao AB
    Model for End-Stage Liver Disease: Is Sex-Based Creatinine Correction a Viable Strategy for Black Females?
    Transplantation. 2015;99:2337-40.
    PubMed     Text format     Abstract available


  239. NOBEL YR, Goldberg DS
    Variable Use of Model for End-Stage Liver Disease Exception Points in Patients With Neuroendocrine Tumors Metastatic to the Liver and Its Impact on Patient Outcomes.
    Transplantation. 2015;99:2341-6.
    PubMed     Text format     Abstract available


    October 2015
  240. ROSSI AP, Vella JP
    Acute Kidney Disease After Liver and Heart Transplantation.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  241. SINGAL AK, Hasanin M, Kaif M, Wiesner R, et al
    Nonalcoholic Steatohepatitis is the Most Rapidly Growing Indication for Simultaneous Liver Kidney Transplantation in the United States.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  242. EDMUNDS C, Ekong UD
    Autoimmune Liver Disease Post Liver Transplantation-A Summary and Proposed Areas for Future Research.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


    September 2015
  243. CASTON JJ, Castells L, Varo E, Gomez MA, et al
    Impact of Cytomegalovirus Infection on Severe Hepatitis C Recurrence in Patients Undergoing Liver Transplantation.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  244. CHOI Y, Yi NJ, Ko JS, Moon JS, et al
    Reappraisal of the Role of Portacaval Shunting in the Growth of Patients With Glycogen Storage Disease Type I in the Era of Liver Transplantation.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  245. LEE J, Yoo YJ, Lee JM, Park YJ, et al
    Sevoflurane Versus Desflurane on the Incidence of Postreperfusion Syndrome During Living Donor Liver Transplantation: A Randomized Controlled Trial.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  246. UEDA Y, Uemoto S
    Interferon-Free Therapy for Hepatitis C in Liver Transplant Recipients.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  247. PAPE E, Scala-Bertola J, Petitpain N, Jouzeau JY, et al
    Management of Tacrolimus-Telaprevir Drug-Drug Interaction in a Liver Transplant Patient With Hepatitis C Virus: Practical Considerations.
    Transplantation. 2015;99:e163-e164.
    PubMed     Text format    


  248. GIACOMONI A, Concone G, Di Sandro S, Lauterio A, et al
    Hepatocellular Carcinoma Progression While on Waiting List for Liver Transplantation.
    Transplantation. 2015;99:e155-e156.
    PubMed     Text format    


  249. MANGUS RS, Fridell JA, Kubal CA, Loeffler AL, et al
    Worse Long-term Patient Survival and Higher Cancer Rates in Liver Transplant Recipients With a History of Smoking.
    Transplantation. 2015;99:1862-1868.
    PubMed     Text format     Abstract available


  250. MANGUS RS, Lutz AJ, Fridell JA, Kubal CA, et al
    Minimal Improvement in Glomerular Filtration Rate in the First Year After Liver Transplantation.
    Transplantation. 2015;99:1855-1861.
    PubMed     Text format     Abstract available


  251. ERICZON BG, Wilczek HE, Larsson M, Wijayatunga P, et al
    Liver Transplantation for Hereditary Transthyretin Amyloidosis: After 20 Years Still the Best Therapeutic Alternative?
    Transplantation. 2015;99:1847-1854.
    PubMed     Text format     Abstract available


  252. MEHROTRA S, Kilambi V, Gilroy R, Ladner DP, et al
    The Authors' Reply.
    Transplantation. 2015;99:e160-1.
    PubMed     Text format    


  253. GENTRY SE, Segev DL, Kasiske BL, Mulligan DC, et al
    Robust Models Support Redistricting Liver Allocation to Reduce Geographic Disparity.
    Transplantation. 2015;99:e159-60.
    PubMed     Text format    


  254. PARAJULI S, Foley D, Djamali A, Mandelbrot D, et al
    Renal Function and Transplantation in Liver Disease.
    Transplantation. 2015;99:1756-64.
    PubMed     Text format     Abstract available


  255. IACOB S, Cicinnati VR, Lindemann M, Heinemann FM, et al
    Donor-Specific Anti-HLA Antibodies and Endothelial C4d Deposition-Association With Chronic Liver Allograft Failure.
    Transplantation. 2015;99:1869-75.
    PubMed     Text format     Abstract available


    August 2015
  256. GEHRAU RC, Mas VR, Dumur CI, Suh JL, et al
    Donor Hepatic Steatosis Induce Exacerbated Ischemia-Reperfusion Injury Through Activation of Innate Immune Response Molecular Pathways.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  257. MCELROY LM, Schmidt KA, Richards CT, Lapin B, et al
    Early Postoperative Emergency Department Care of Abdominal Transplant Recipients.
    Transplantation. 2015;99:1652-7.
    PubMed     Text format     Abstract available


  258. BECKER BN, Becker YT
    Evaluating the Emergency Department as a Site of Transplant Care.
    Transplantation. 2015;99:1549-50.
    PubMed     Text format    


  259. RAVAIOLI M, Neri F, Lazzarotto T, Bertuzzo VR, et al
    Immunosuppression Modifications Based on an Immune Response Assay: Results of a Randomized, Controlled Trial.
    Transplantation. 2015;99:1625-32.
    PubMed     Text format     Abstract available


    July 2015
  260. LOCKE JE, Durand C, Reed RD, MacLennan PA, et al
    Long-Term Outcomes After Liver Transplantation Among Human Immunodeficiency Virus-Infected Recipients.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  261. PATERNO F, Wima K, Hoehn RS, Cuffy MC, et al
    Use of Elderly Allografts in Liver Transplantation.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  262. FISCHER L, Saliba F, Kaiser GM, De Carlis L, et al
    Three-year Outcomes in De Novo Liver Transplant Patients Receiving Everolimus With Reduced Tacrolimus: Follow-Up Results From a Randomized, Multicenter Study.
    Transplantation. 2015;99:1455-62.
    PubMed     Text format     Abstract available


  263. SEMER NB
    Awaiting Liver Transplantation.
    Transplantation. 2015;99:e48.
    PubMed     Text format    


  264. CHAPMAN JR, Pomfret EA
    President's Address: International Liver Transplantation Society.
    Transplantation. 2015;99:1301.
    PubMed     Text format    


    June 2015
  265. SINGH N, Winston DJ, Limaye AP, Pelletier S, et al
    Performance Characteristics of Galactomannan and beta-d-Glucan in High-Risk Liver Transplant Recipients.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  266. GHABRIL M, Agarwal S, Lacerda M, Chalasani N, et al
    Portal Vein Thrombosis Is a Risk Factor for Poor Early Outcomes After Liver Transplantation: Analysis of Risk Factors and Outcomes for Portal Vein Thrombosis in Waitlisted Patients.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  267. SHAPIRO AM
    Donor-Specific Antibody in Pediatric Liver Transplantation-Identifying a Tree by its Fruit.
    Transplantation. 2015.
    PubMed     Text format    


  268. ROCHE B, Roque-Afonso AM, Nevens F, Samuel D, et al
    Rational Basis for Optimizing Short and Long-Term Hepatitis B Virus Prophylaxis Post Liver Transplantation. Role of Hepatitis B Immune Globulin.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  269. WOZNIAK LJ, Hickey MJ, Venick RS, Vargas JH, et al
    Donor-Specific HLA Antibodies Are Associated With Late Allograft Dysfunction After Pediatric Liver Transplantation.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  270. ALHAMAD T, Uemura T, Lehman E, Spatz C, et al
    Utilization of donors after cardiac death organs for simultaneous liver and kidney transplantation.
    Transplantation. 2015;99:e40-1.
    PubMed     Text format    


  271. WADEI HM, Taner CB
    Simultaneous liver-kidney transplantation from donation after cardiac death donors: is there a better way to use these organs?
    Transplantation. 2015;99:e39.
    PubMed     Text format    


  272. ASCHER NL
    Nancy L. Ascher, MD, PhD: Professor and Chair, Department of Surgery, UCSF; Past-President, ASTS; President-elect, The Transplantation Society.
    Transplantation. 2015;99:1106.
    PubMed     Text format    


  273. GOLDIN MM, Khubutia MSh, Evseev AK, Goldin MM, et al
    Noninvasive diagnosis of dysfunctions in patients after organ transplantation by monitoring the redox potential of blood serum.
    Transplantation. 2015;99:1288-92.
    PubMed     Text format     Abstract available


  274. WU G, Cruz RJ
    Liver inclusion improves outcomes of intestinal retransplantation in adults.
    Transplantation. 2015;99:1265-72.
    PubMed     Text format     Abstract available


    May 2015
  275. HAYASHI K, Uchida H, Takaoka C, Izawa Y, et al
    Discrepancy in Psychological Attitudes Toward Living Donor Liver Transplantation Between Recipients and Donors.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  276. SCHNITZBAUER AA, Sothmann J, Baier L, Bein T, et al
    Calcineurin Inhibitor Free De Novo Immunosuppression in Liver Transplant Recipients With Pretransplant Renal Impairment: Results of a Pilot Study (PATRON07).
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  277. CHENG Q, He SQ, Gao D, Lei B, et al
    Early Application of Auxiliary Partial Orthotopic Liver Transplantation in Murine Model of Wilson Disease.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  278. GOLSE N, Bucur PO, Faitot F, Bekheit M, et al
    Spontaneous Splenorenal Shunt in Liver Transplantation: Results of Left Renal Vein Ligation Versus Renoportal Anastomosis.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  279. LONGENECKER JC, Estrella MM, Segev DL, Atta MG, et al
    Patterns of Kidney Function Before and After Orthotopic Liver Transplant: Associations With Length of Hospital Stay, Progression to End-Stage Renal Disease, and Mortality.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  280. MOROSO V, van Cranenbroek B, Mancham S, Sideras K, et al
    Prominent HLA-G Expression in Liver Disease But Not After Liver Transplantation.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


    April 2015
  281. SALEM R, Vouche M, Baker T, Herrero JI, et al
    Pretransplant Portal Vein Recanalization-Transjugular Intrahepatic Portosystemic Shunt in Patients With Complete Obliterative Portal Vein Thrombosis.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


    March 2015
  282. SINGH N, Sifri CD, Silveira FP, Miller R, et al
    Cryptococcosis in Patients With Cirrhosis of the Liver and Posttransplant Outcomes.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  283. RANA A, Kaplan B, Riaz IB, Porubsky M, et al
    Geographic inequities in liver allograft supply and demand: does it affect patient outcomes?
    Transplantation. 2015;99:515-20.
    PubMed     Text format     Abstract available


  284. CEULEMANS LJ, De Hertogh G, Van Cromphaut S, Vermeire S, et al
    Nonsteroidal anti-inflammatory drug-induced intestinal graft loss 12 years after transplantation.
    Transplantation. 2015;99:e18-9.
    PubMed     Text format    


  285. VERGHESE PS, Schmeling DO, Knight JA, Matas AJ, et al
    The impact of donor viral replication at transplant on recipient infections posttransplant: a prospective study.
    Transplantation. 2015;99:602-8.
    PubMed     Text format     Abstract available


    February 2015
  286. KOIKE K, Takaki A, Yagi T, Iwasaki Y, et al
    Enhancement of Programmed Death Ligand 2 on Hepatitis C Virus Infected Hepatocytes by Calcineurin Inhibitors.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  287. MEHROTRA S, Kilambi V, Gilroy R, Ladner DP, et al
    Modeling the allocation system: principles for robust design before restructuring.
    Transplantation. 2015;99:278-81.
    PubMed     Text format     Abstract available


    August 2014
  288. CHANG Y, Gallon L, Shetty K, Chang Y, et al
    Simulation Modeling of the Impact of Proposed New Simultaneous Liver and Kidney Transplantation Policies.
    Transplantation. 2014.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Transplantation is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: